Understanding the Socio-Economic and Demographic Factors Affecting Uptake of Second Dose Measles Vaccination (MCV2) among Children Under 5 in Ebonyi State, South-Eastern Nigeria
Abstract:
Measles is a highly contagious viral disease that poses a significant
threat to children worldwide. Vaccination programs have been successful in
reducing the burden of measles, but the complete protection against the disease
requires two doses of the measles-containing vaccine (MCV 2). The study sought
to identify the socio-economic and demographic factors that affect uptake of
second dose of measles vaccine (MCV2) and explore the opportunities available
to mitigate the challenges in Ebonyi state. Community-based cross-sectional
study was conducted in the selected areas. One focal health facility was
selected in each LGA, and the target population was the birth cohort of
children born between 22nd March 2021 and 22nd February
2022. The adjusted sample size for this study is 409. Results/Factors identified are child got sick after first dose, no
chance to go to facility, frequent cancellation of immunization sessions,
caregivers not aware of the second dose, forgetfulness, assumption of first
dose being adequate for the child, relocation, no vaccine at facility and 69%
of mothers and caregivers are worried that vaccines can cause a child to be
sick. Among socio-demographic characteristics; there are no significant
association between MCV 2 and age of the mother, maternal educational status,
family monthly income, family size, and number of children alive. However, the
study showed significant association between maternal occupation and vaccine
out of stock at the health facility with low uptake of MCV2. Therefore, health
education on the importance of MCV2 should be intensified at all levels.
References:
[1].
Wang, R., Jing, W.,
Liu, M., Liu, J., 2022, Trends of the Global, Regional, and National Incidence
of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to
2019. Front Med. Jan 20;8.
[2].
Tsegaye, G.,
Gezahegn, Y., Tesfaye, A., Mulatu, G., Bulcha, G. G., Berhanu, N., 2021,
Measles Outbreak Investigation in Guradamole District of Bale Zone, South
Eastern Ethiopia, Infect Drug Resist. 15:669–83.
[3].
Perry, R. T., Murray,
J. S., Gacic-dobo, M., Dabbagh, A., 2020, Progress towards Regional Measles
Elimination, Worldwide, 2000 – 2014 Progrès Accomplis dans le monde en vue de
l’ élimination régionale de la rougeole.
[4].
Gastañaduy, P. A.,
Goodson, J. L., Panagiotakopoulos, L., Rota, P. A, Orenstein, W. A., Patel, M.,
2021, Measles in the 21st Century: Progress Toward Achieving and Sustaining
Elimination, Journal for Infectious Diseases., Sep;224(12 Suppl
2):S420–8.
[5].
Umoke, P. C. I.,
Umoke, M., Nwalieji, C. A., Igwe, F. O., Umoke, U. G., Onwe, R. N., et al,
2021. Investigating Factors Associated with Immunization Incompletion of
Children Under Five in Ebonyi State, Southeast Nigeria: Implication for Policy
Dialogue, Global Pediatric Health., 8:2333794X21991008.
[6].
Mantel, C., Cherian,
T., 2020, New Immunization Strategies: Adapting to Global Challenges. Bundesgesundheitsblatt
Gesundheitsforschung Gesundheitsschutz, Jan;63(1):25–31.
[7].
Gizaw, Z., Astale, T.,
Kassie, G. M., 2022, What Improves Access to Primary Healthcare Services In
Rural Communities? A Systematic Review. BMC Primary Care.,
Dec;23(1):313.
[8].
Onoja, B., Ajagbe,
O., 2019, Measles in Developing Countries In 2019.
[9].
Tadesse, A. W., Sahlu,
D., Benayew, M., 2022, Second-Dose Measles Vaccination and Associated Factors
Among Under-Five Children in Urban Areas of North Shoa Zone, Central Ethiopia, Front
Public Heal. 2022;10:1029740.
[10]. Chilot, D., Belay, D. G., Shitu, K., Gela, Y. Y., Getnet, M., Mulat, B., et
al., 2022, Measles Second Dose Vaccine Utilization and Associated Factors Among
Children Aged 24-35 Months in Sub-Saharan Africa, A Multi-Level Analysis from
Recent Dhs Surveys, BMC Public Health. Nov;22(1):2070.
[11]. WHO Organization, 2018, WH. Immunization Coverage, Geneva, Switzerland,
Available from: https://www.who.int/mediacentre/factsheets/fs378/en
[12]. Jaffar, H. M. O., 2021, Timely Uptake of the Second Dose of Measles Vaccine
and Associated Factors Among Eligible Children in Shinyanga District, Tanzania.
[13]. Sacre, A., Bambra, C., Wildman, J. M., Thomson, K., Sowden, S., Todd, A.,
2022, Socioeconomic Inequalities and Vaccine Uptake: An Umbrella Review
Protocol. Int J Environ Res Public Health, Sep;19(18).
[14]. Taffie, W., Temesgen, H., Ashebir, W., Mekonen, H., 2024, Measles Second
Dose Vaccine Uptake and its Associated Factors among Children Aged 24-35 Months
in Northwest Ethiopia, Sci Rep., May;14(1):11059.
[15]. WHO., 2022, Measles Facts Sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
[16]. Akwataghibe, N. N., Ogunsola, E. A., Broerse, J. E. W., Popoola, O. A.,
Agbo, A. I., Dieleman, M. A., 2019, Exploring Factors Influencing Immunization
Utilization in Nigeria-A Mixed Methods Study. Frontline Public Health.,
7:392.
[17]. Balgovind, P., and Mohammadnezhad, M., 2022, Factors Affecting Childhood
Immunization: Thematic Analysis of Parents and Healthcare Workers’ Perceptions.
Hum Vaccin Immunother., Nov;18(6):2137338.
[18]. Minta, A. A., Ferrari, M., Antoni, S., Portnoy, A., Sbarra, A., Lambert, B.,
et al., 2022, Progress Toward Regional Measles Elimination - Worldwide,
2000-2021. MMWR Morb Mortal Wkly Rep., Nov;71(47):1489–95.
[19]. WHO., 2024, Measles Fact sheets, Available from: https://www.who.int/news-room/fact-sheets/detail/measles
[20]. Balcha, G., Masresha, R. L., Joseph, O., Messeret, E. S., Raoul, K. A. F.
2018, Introduction of the Second Dose of Measles Containing Vaccine in the
Childhood Vaccination Programs Within the WHO Affrica Region- Lessons Learnt. Journal
of Immunology Science [Internet]; Available from: https://pubmed.ncbi.nlm.nih.gov/30766972/#article-details
[21]. DHIS2, 2022, EVOLUTION (TIMELINESS , QUALITY , AND COMPLETION) IN NIGERIA
TO MONITOR CHILD HEALTH QUALITY OF CARE USAID Integrated Health Project (IHP)
Nigeria. 2022;2.
[22]. Mamuti, S., Tabu, C., Marete, I., Opili, D., Jalang’o R., and Abade, A.,
2022, Measles Containing Vaccine Coverage and Factors Associated with its Uptake
Among Children Aged 24-59 Months in Cherangany Sub County, Trans Nzoia County,
Kenya. PLoS One. 17(2):e0263780.
[23]. Masreshan B. G, Shibeshi, M., Luce, R., Ntsama, B., N’Diaye, A., Chakauya,
J., et al., 2020, The Performance of Routine Immunization in Selected African Countries
During the First Six Months of the COVID-19 Pandemic. Pan African Medical
Journal. Sep 18;37.
[24]. Mahachi, K., Kessels, J., Boateng, K., Jean Baptiste, A. E., Mitula, P.,
Ekeman, E., et al., 2022, Zero- or Missed-Dose Children in Nigeria:
Contributing Factors and Interventions to Overcome Immunization Service
Delivery Challenges. Vaccine, Sep;40(37):5433–44.
[25]. Ogutu, J. O., 2020, Factors Associated with Low Coverage of the Second Dose
of Measles Containing Vaccine among Children Aged 19-59 Months, Alego-Usonga
Sub-County, Kenya, 2020. J Interv Epidemiol Public Health, 6(1).
[26]. Sato, R., 2020, Association between Access to a Health Facility and
Continuum of Vaccination Behaviors among Nigerian Children. Human Vaccine
Immunotherapeutics. May;16(5):1215–20.
[27]. Melis, T., Mose, A., Fikadu, Y., Haile, K., Habte, A., Jofiro, G., 2024,
Predictors for Low Coverage of Uptake of Second Dose of Measles Vaccine Among
Children in Sub-Saharan Africa, 2023: A Systematic Review and Meta-Analysis. Journal
of Pharmacology Policy Practice. 17(1):2285507.
[28]. Teshale, A. B., Amare, T., 2023, Exploring Spatial Variations and the
Individual and Contextual Factors of Uptake of Measles-Containing Second Dose
Vaccine Among Children Aged 24 to 35 months in Ethiopia. PLoS One,
18(1):e0280083.
[29]. Magodi, R., Mmbaga, E. J., Massaga, J., Lyimo, D., Mphuru, A., Abade, A.,
2019, Factors Associated With Non-Uptake Of Measles-Rubella Vaccine Second Dose
Among Children under Five years in Mtwara District Council, Tanzania, 2017. Pan
African Medical Journal. 33:67.
[30]. Munyithya, J. M., Mwenda, C., Omondi, M. P., Francisca, M., 2022, Factors
Associated with Measles-Rubella Vaccine Second Dose Uptake among Children Aged
19-59 Months at Mwingi Central Sub County, 35(5):608–19.
[31]. Nchimunya, M., Chanda, D., Musenge, E., 2023, Factors Contributing to the
Acceptability of Second Dose of Measles Vaccine among Children in Livingstone
District, Zambia, 220–34.
[32]. Atnafu, A., Andargie, G., Yitayal, M., Ayele, T. A., Alemu, K., Demissie, G.
D., et al., 2020, Prevalence and Determinants Of Incomplete Or Not At All
Vaccination Among Children Aged 12 – 36 Months in Dabat and Gondar Districts,
Northwest of Ethiopia: Findings from the Primary Health Care Project;1–6.
[33]. Abdulraheem, I., Onajole, A., Jimoh, A., Oladipo, A. R., 2011, Reasons for Incomplete
Vaccination and Factors for Missed Opportunities Among Rural Nigerian Children.
Journal of Public Health Epidemiology. Jan 1;3:194–203.
[34]. Jain, M., Shisler, S., Lane, C., Bagai, A., Brown, E., Engelbert, M., 2022,
Use of Community Engagement Interventions to Improve Child Immunisation in Low-Income
and Middle-Income Countries: A Systematic Review and Meta-Analysis. BMJ Open.
Nov;12(11):e061568.
[35]. Opel, D. J, Heritage, J., Taylor, J. A., Mangione-Smith, R., Salas, H. S,
Devere, V., et al., 2013, The Architecture of Provider-Parent Vaccine
Discussions at Health Supervision Visits. Pediatrics. Dec;132(6):1037–46.
[36]. Iwu-Jaja, C. J., Jordan, P., Ngcobo, N., Jaca, A., Iwu, C. D., Mulenga, M.,
et al., 2022, Improving the Availability of Vaccines in Primary Healthcare
Facilities in South Africa: Is the time Right for A System Redesign Process? Human
Vaccine Immunotherapeutics. Dec;18(1):1926184.
[37]. Groom, H., Hopkins, D. P., Pabst, L. J, Murphy, Morgan, J, Patel, M.,
Calonge, N, et al., 2015, Immunization Information Systems to Increase
Vaccination Rates: A Community Guide Systematic Review. Journal of Public
Health Management, Practice, 21(3):227–48.
[38]. Bryant, A. R., 2016, ScholarWorks @ Georgia State University Electronic
Health Records and Immunization Information Systems Interoperability: Measuring
Impact on Immunization Outcomes.
[39]. Sampene, A. K., Li, C., Oteng Agyeman, F., & Brenya, R., 2023, Socioeconomic and Demographic Characteristics Influencing the Hesitancy and Refusal of COVID-19 Vaccine in Ghana. Therapeutic Advances in Vaccines and Immunotherapy. https://doi.org/10.1177/25151355221149336
